Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Milene Saavedra

Concepts (212)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
30
2026
1164
3.000
Why?
Rhinitis
9
2025
159
1.590
Why?
Sinusitis
9
2025
221
1.500
Why?
Pseudomonas Infections
10
2022
229
1.360
Why?
Pseudomonas aeruginosa
12
2023
392
0.840
Why?
Olfaction Disorders
4
2026
74
0.660
Why?
Azithromycin
6
2020
101
0.610
Why?
Anti-Bacterial Agents
10
2022
1942
0.530
Why?
Minimal Clinically Important Difference
3
2026
35
0.480
Why?
C-Reactive Protein
2
2018
429
0.480
Why?
Smell
3
2026
129
0.470
Why?
Neutrophils
6
2020
1133
0.460
Why?
Tobramycin
5
2019
63
0.410
Why?
Aminophenols
4
2024
204
0.400
Why?
Gene Expression Profiling
4
2018
1792
0.400
Why?
Mycobacterium Infections, Nontuberculous
3
2022
339
0.380
Why?
Chronic Disease
10
2026
1827
0.370
Why?
Respiratory Mucosa
2
2008
323
0.360
Why?
Prospective Studies
10
2026
8123
0.310
Why?
Mycobacterium abscessus
2
2022
110
0.300
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
7
2024
373
0.300
Why?
Radiographic Image Enhancement
1
2009
57
0.290
Why?
Kruppel-Like Transcription Factors
2
2008
83
0.270
Why?
RNA Precursors
1
2008
155
0.250
Why?
Benzodioxoles
3
2024
164
0.250
Why?
Radiology
1
2009
175
0.250
Why?
Quality of Life
5
2026
3200
0.230
Why?
Sputum
4
2022
302
0.220
Why?
Administration, Inhalation
3
2022
567
0.220
Why?
Biomarkers
5
2022
4340
0.200
Why?
Forced Expiratory Volume
6
2019
451
0.200
Why?
Food Preferences
1
2025
126
0.200
Why?
Indoles
2
2024
511
0.190
Why?
Medication Adherence
2
2025
535
0.190
Why?
Leukocytes
2
2018
301
0.180
Why?
Humans
37
2026
146342
0.180
Why?
Lipopolysaccharides
2
2020
861
0.170
Why?
Adult
18
2026
41087
0.170
Why?
Self Efficacy
1
2025
418
0.170
Why?
Quinolones
4
2024
204
0.160
Why?
Tomography, X-Ray Computed
2
2014
2786
0.150
Why?
Aztreonam
2
2016
12
0.150
Why?
Feedback
1
2020
183
0.150
Why?
Colistin
1
2019
10
0.150
Why?
Inflammation
3
2022
2919
0.150
Why?
Iron
1
2002
359
0.150
Why?
Mycobacterium tuberculosis
1
2022
325
0.140
Why?
Receptors, Interleukin-8B
1
2018
29
0.140
Why?
British Columbia
1
2018
27
0.140
Why?
Mental Health
1
2025
779
0.130
Why?
Endoscopy
3
2026
316
0.130
Why?
Severity of Illness Index
4
2024
2921
0.130
Why?
Male
21
2026
73396
0.130
Why?
Anxiety
1
2025
1125
0.130
Why?
Young Adult
9
2026
14330
0.130
Why?
Morbidity
1
2018
319
0.130
Why?
Disease Progression
4
2019
2867
0.130
Why?
Female
21
2026
79499
0.130
Why?
Host-Pathogen Interactions
1
2020
366
0.120
Why?
Drug Combinations
3
2024
400
0.120
Why?
Adrenal Cortex Hormones
1
2018
486
0.110
Why?
Interferons
1
2016
186
0.110
Why?
Depression
1
2025
1575
0.110
Why?
Metalloproteases
1
2014
42
0.100
Why?
RNA, Messenger
1
2022
2791
0.100
Why?
Quorum Sensing
1
2014
80
0.100
Why?
Interleukin-8
2
2020
268
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2008
974
0.100
Why?
Apoptosis
1
2002
2439
0.100
Why?
Survival Rate
1
2018
2092
0.100
Why?
Lung
5
2023
4122
0.090
Why?
Cytokines
3
2015
2081
0.090
Why?
Virulence Factors
1
2014
175
0.090
Why?
Mycobacterium Infections
1
2013
55
0.090
Why?
Neutrophil Activation
1
2013
84
0.090
Why?
Wound Infection
1
2013
60
0.090
Why?
Mycobacterium
1
2013
102
0.090
Why?
Prognosis
2
2018
4351
0.090
Why?
Promoter Regions, Genetic
2
2008
1242
0.090
Why?
Cellular Structures
1
2011
6
0.090
Why?
Biofilms
3
2014
288
0.090
Why?
Middle Aged
11
2026
36619
0.090
Why?
Surveys and Questionnaires
4
2025
6073
0.090
Why?
Gene Expression Regulation
2
2020
2599
0.080
Why?
Microbial Viability
1
2011
83
0.080
Why?
Extracellular Space
1
2011
118
0.080
Why?
Treatment Outcome
6
2024
11821
0.080
Why?
Enzyme Induction
2
2008
87
0.080
Why?
Nontuberculous Mycobacteria
2
2022
189
0.080
Why?
Tumor Necrosis Factor-alpha
2
2008
1224
0.080
Why?
Paranasal Sinuses
2
2024
77
0.080
Why?
Colorado
2
2018
4595
0.080
Why?
Pyridines
2
2024
610
0.070
Why?
Predictive Value of Tests
2
2020
2113
0.070
Why?
Protein Array Analysis
1
2009
56
0.070
Why?
Transcription, Genetic
2
2008
1432
0.070
Why?
Nasal Polyps
1
2009
59
0.070
Why?
Immunoglobulin G
2
2023
901
0.070
Why?
Follow-Up Studies
1
2018
5439
0.070
Why?
Time Factors
2
2018
7109
0.070
Why?
Burns
1
2013
365
0.070
Why?
Mutation
2
2021
4093
0.070
Why?
Spirometry
1
2008
234
0.070
Why?
Nitric Oxide Synthase Type II
1
2008
162
0.060
Why?
NF-kappa B
2
2008
674
0.060
Why?
Case-Control Studies
4
2020
3647
0.060
Why?
Interleukins
1
2008
248
0.060
Why?
Oligonucleotide Array Sequence Analysis
1
2008
752
0.060
Why?
ROC Curve
1
2008
617
0.060
Why?
Enzyme Activation
1
2008
759
0.060
Why?
Survivors
1
2010
526
0.060
Why?
Aspirin
1
2009
405
0.060
Why?
Acute Disease
1
2008
1038
0.060
Why?
Cell Line
2
2008
2814
0.050
Why?
Phospholipases A
1
2005
97
0.050
Why?
Cytosol
1
2005
215
0.050
Why?
Cohort Studies
2
2020
6077
0.050
Why?
Epithelial Cells
2
2008
1119
0.050
Why?
Drug Interactions
2
2016
405
0.050
Why?
Observational Studies as Topic
1
2024
133
0.050
Why?
Pseudomonas
1
2023
30
0.050
Why?
Logistic Models
2
2019
2126
0.050
Why?
Cell Separation
2
2016
300
0.050
Why?
Pyrrolidines
1
2023
127
0.050
Why?
Trans-Activators
1
2005
372
0.050
Why?
Social Class
1
2024
260
0.040
Why?
In Situ Nick-End Labeling
1
2002
120
0.040
Why?
HIV-1
1
2008
913
0.040
Why?
Self-Management
1
2025
207
0.040
Why?
Chemokine CCL2
1
2002
112
0.040
Why?
Microbial Sensitivity Tests
2
2014
367
0.040
Why?
Protease Inhibitors
1
2002
103
0.040
Why?
Chemokine CCL4
1
2020
31
0.040
Why?
Anti-HIV Agents
1
2008
914
0.040
Why?
Chloroquine
1
2020
54
0.040
Why?
Reproducibility of Results
1
2008
3416
0.040
Why?
Bronchi
1
2002
263
0.040
Why?
Adolescent
4
2026
22557
0.040
Why?
Primary Cell Culture
1
2020
173
0.040
Why?
Pyrazoles
1
2023
517
0.040
Why?
Tetraspanin 30
1
2018
11
0.040
Why?
Cells, Cultured
2
2008
4118
0.040
Why?
Protein Biosynthesis
1
2002
449
0.040
Why?
Sirolimus
1
2020
282
0.030
Why?
Administration, Intravenous
1
2019
172
0.030
Why?
Phagocytosis
1
2020
298
0.030
Why?
Survival Analysis
2
2016
1378
0.030
Why?
Homozygote
1
2018
197
0.030
Why?
Sex Factors
1
2024
2107
0.030
Why?
Aminopyridines
1
2018
128
0.030
Why?
Autophagy
1
2020
290
0.030
Why?
Child
3
2020
22693
0.030
Why?
Reactive Oxygen Species
1
2020
610
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2020
429
0.030
Why?
Gene Deletion
1
2018
385
0.030
Why?
Drug Administration Routes
1
2016
41
0.030
Why?
Immunosuppressive Agents
1
2020
829
0.030
Why?
Genotype
2
2014
1879
0.030
Why?
Interferon-alpha
1
2016
201
0.030
Why?
Respiratory Function Tests
1
2016
543
0.030
Why?
Retrospective Studies
4
2019
17438
0.030
Why?
Pilot Projects
1
2020
1888
0.030
Why?
Sweat
1
2014
52
0.030
Why?
RNA, Small Interfering
2
2008
633
0.030
Why?
Drug Resistance, Multiple, Bacterial
1
2014
77
0.030
Why?
Kaplan-Meier Estimate
1
2016
970
0.030
Why?
Odds Ratio
1
2016
1077
0.020
Why?
Chlorides
1
2014
138
0.020
Why?
Cross-Sectional Studies
1
2025
5899
0.020
Why?
Drug Monitoring
1
2016
399
0.020
Why?
Ciprofloxacin
1
2013
31
0.020
Why?
Multivariate Analysis
1
2016
1543
0.020
Why?
Superoxides
1
2013
198
0.020
Why?
Drug Synergism
1
2013
354
0.020
Why?
Suspensions
1
2011
28
0.020
Why?
Mice
2
2023
18297
0.020
Why?
Risk Factors
2
2016
10921
0.020
Why?
DNA
2
2008
1421
0.020
Why?
Drug Therapy, Combination
1
2013
1036
0.020
Why?
Cell Adhesion
1
2011
447
0.020
Why?
Adaptor Protein Complex beta Subunits
1
2009
2
0.020
Why?
Caspase 8
1
2009
48
0.020
Why?
Caspase 9
1
2009
54
0.020
Why?
Age Distribution
1
2010
399
0.020
Why?
Sex Distribution
1
2010
382
0.020
Why?
Animals
3
2023
38106
0.020
Why?
Drug Tolerance
1
2009
100
0.020
Why?
HSP70 Heat-Shock Proteins
1
2009
76
0.020
Why?
HIV Core Protein p24
1
2008
32
0.020
Why?
Age of Onset
1
2010
558
0.020
Why?
Transcription Factor AP-1
1
2008
76
0.020
Why?
Signal Transduction
1
2020
5246
0.020
Why?
Up-Regulation
1
2008
841
0.010
Why?
Phospholipases A2
1
2005
78
0.010
Why?
Two-Hybrid System Techniques
1
2005
59
0.010
Why?
Group IV Phospholipases A2
1
2005
46
0.010
Why?
Exocrine Pancreatic Insufficiency
1
2004
25
0.010
Why?
Electrophoretic Mobility Shift Assay
1
2005
90
0.010
Why?
Early Diagnosis
1
2004
251
0.010
Why?
Drosophila
1
2005
168
0.010
Why?
Patient Acceptance of Health Care
1
2010
881
0.010
Why?
Actins
1
2005
422
0.010
Why?
Transfection
1
2005
916
0.010
Why?
Disease Models, Animal
1
2013
4580
0.010
Why?
Protein Binding
1
2008
2244
0.010
Why?
Registries
1
2010
2400
0.010
Why?
Phosphorylation
1
2005
1724
0.010
Why?
Aged
2
2010
26432
0.010
Why?
Cell Line, Tumor
1
2005
3545
0.010
Why?
Carcinoma, Non-Small-Cell Lung
1
2005
1195
0.010
Why?
Lung Neoplasms
1
2005
2675
0.010
Why?
Child, Preschool
1
2004
11913
0.000
Why?
Saavedra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)